Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADARB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AFDN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYL12A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2AFZ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DYRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABHD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOK5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL13AP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP135 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIVM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on